On Monday, a state-funded committee in Louisiana gave Mark Cuban’s Cost Plus Drug Company a taxpayer-funded microphone to ...

Prescription drug prices are complex and vary across insurance, pharmacies, and discount platforms like GoodRx. Learn how PBMs, Medicare Part D, and new models like Cost Plus Drugs affect your costs ...

Matt Cover’s Sept. 23 op-ed sought to paint pharmacy benefit managers (PBMs) as good actors trying to keep prices low for ...

The Louisiana Legislature didn't ban PBM vertical integration. But state leaders are still working on ways to limit to power ...

The news of a possible government-run drug website comes alongside Health and Human Services Secretary Robert F. Kennedy ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the ...

Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs ...

But plans can remove medications from their drug lists, add prior authorization restrictions and even increase deductibles ...

The potential of AI to analyse vast quantities of data in a relatively short time frame makes its application to the ...

In this week’s edition of InnovationRx, we look at a startup working to fix drug pricing, Pfizer’s obesity bet and more.

In healthcare, due to decades of cost-plus reimbursement, there have been no incentives for efficiency. Hospitals, for example, react only to the visible outcomes of a dysfunctional ...